Butzkueven, Helmut
Licata, Stephanie http://orcid.org/0000-0002-7953-3867
Jeffery, Douglas
Arnold, Douglas L
Filippi, Massimo
Geurts, Jeroen JG
Santra, Sourav
Campbell, Nolan
Ho, Pei-Ran
Clinical trials referenced in this document:
Documents that mention this clinical trial
Natalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head study
https://doi.org/10.1136/bmjopen-2020-038861
Documents that mention this clinical trial
Natalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head study
https://doi.org/10.1136/bmjopen-2020-038861
Funding for this research was provided by:
Biogen (N/A)